Myeloid Therapeutics
Myeloid Therapeutics


Cambridge, MA, USA · Cambridge, MA, USA


Biotechnology · DeepTech · Health


11-50 employees


Series A

founded in


Myeloid Therapeutics is an immunology company focused on combining immunologic insights with cutting-edge technologies to harness myeloid cells to eradicate cancer and other diseases. The Company's ATAKTM platform technology can be broadly applied, and it is initially advancing a cell therapy program for T cell lymphoma and a primed monocyte approach to treat glioblastoma. The ATAK platform is scalable to multiple treatment modalities and other disease areas in collaboration with partners.

Something looks off?
Open jobs at Myeloid Therapeutics

On-site & Remote